Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Vaccines

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1758172

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1758172

Digital Vaccines

PUBLISHED:
PAGES: 274 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Digital Vaccines Market to Reach US$3.1 Billion by 2030

The global market for Digital Vaccines estimated at US$1.8 Billion in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Smartphones Device, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Tablets Device segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$496.5 Million While China is Forecast to Grow at 12.7% CAGR

The Digital Vaccines market in the U.S. is estimated at US$496.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$627.8 Million by the year 2030 trailing a CAGR of 12.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

Global Digital Vaccines Market - Key Trends & Drivers Summarized

What Are Digital Vaccines and Why Are They Redefining Preventive Healthcare?

Digital vaccines represent a new paradigm in preventive health, utilizing digital platforms and neurocognitive training to influence behavior, boost resilience, and strengthen immunity against disease-not through biological agents, but via behavioral conditioning and neural modulation. Delivered via smartphones, tablets, or virtual reality systems, digital vaccines are software-based interventions that engage users in structured exercises designed to prevent conditions such as stress, anxiety, addiction, or even infectious diseases by altering behavior and improving mental and physiological response patterns.

Unlike conventional vaccines that stimulate an immune response through antigens, digital vaccines operate by activating brain circuits to train the nervous system and enhance behavioral immunity. These solutions are especially relevant in tackling mental health disorders, behavioral dependencies, and lifestyle diseases. In children, for example, digital vaccines are being developed to promote social-emotional learning and cognitive skills to reduce susceptibility to anxiety or peer pressure-induced behaviors. In adults, these tools aim to condition stress responses, reduce smoking or drinking habits, and promote cognitive resilience.

Which Technologies Are Powering the Emergence of Digital Vaccine Platforms?

Digital vaccines rely on an array of cognitive computing technologies, including artificial intelligence, gamification, neurobehavioral algorithms, and adaptive learning models. Mobile applications serve as the primary delivery interface, while AI is used to customize cognitive tasks based on the user’s behavioral data and performance patterns. Neurofeedback, eye tracking, and biometric monitoring are also being incorporated to measure engagement and tailor interventions dynamically.

Machine learning models analyze real-time data to optimize intervention intensity, duration, and complexity, ensuring that users receive the right “dose” of digital therapy. Augmented reality (AR) and virtual reality (VR) interfaces are being used to enhance immersion and efficacy, particularly for anxiety reduction or phobia desensitization. Some platforms integrate with wearables to monitor stress markers like heart rate variability or galvanic skin response, which helps in calibrating the cognitive load and response profile of the digital vaccine session.

Which End-Use Segments Are Driving Adoption of Digital Vaccine Technologies?

The education sector, especially K-12 and early childhood programs, is one of the most active adopters of digital vaccines, using them to build emotional intelligence, self-regulation, and social adaptability among children. These tools are embedded into learning curriculums or deployed as standalone applications to improve psychological readiness, particularly in vulnerable or trauma-affected populations. Pediatric healthcare providers are exploring digital vaccines as adjuncts to ADHD, behavioral therapy, and autism spectrum interventions.

In corporate wellness and mental health programs, digital vaccines are gaining popularity to mitigate burnout, improve cognitive function, and train emotional resilience among employees. Healthcare systems and insurers are beginning to evaluate these tools for non-clinical preventive care, particularly in high-risk populations. Digital therapeutics firms and neuroscience startups are also launching condition-specific vaccines for issues like substance abuse, depression, and chronic stress, expanding the role of digital health in behavioral medicine.

What Factors Are Driving the Growth of the Digital Vaccines Market?

The growth in the digital vaccines market is driven by several factors, including the increasing need for scalable mental health interventions, growing acceptance of non-pharmaceutical preventive care, and rising investment in cognitive health platforms. The rising burden of mental disorders, lifestyle-induced health problems, and behavioral risk factors across all age groups is pushing governments and employers to seek accessible and cost-effective solutions-something digital vaccines are well-positioned to offer.

End-use trends such as the proliferation of mobile health apps, the rising deployment of behavioral AI in wellness programs, integration of digital therapeutics into clinical care, and expanding emphasis on emotional learning in educational settings are fueling adoption. Moreover, the convergence of neuroscience, behavioral science, and digital technology is enabling continuous refinement of digital vaccine efficacy. As healthcare shifts toward personalized and proactive care models, digital vaccines are emerging as a vital layer in the global health prevention toolkit-blending cognitive science with digital accessibility to protect mental and behavioral well-being.

SCOPE OF STUDY:

The report analyzes the Digital Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Smartphones Device, Tablets Device, Other Devices); Application (Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • Bharat Biotech International
  • BioNTech SE
  • CanSino Biologics Inc.
  • CureVac N.V.
  • Dynavax Technologies Corp.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc (GSK)
  • Inovio Pharmaceuticals Inc.
  • Johnson & Johnson Services
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India
  • Sinovac Biotech Ltd.
  • Stablepharma Ltd
  • Vaxart, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP36721

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Digital Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Focus on Neurological and Behavioral Health Drives Interest in Cognitive-Based Digital Vaccines
    • OEM Development of Game-Like Therapeutic Platforms Throws Spotlight on Software-Based Immunomodulation
    • Clinical Validation of Neuromodulatory Mechanisms Strengthens Evidence Base for Digital Vaccine Efficacy
    • Rising Burden of ADHD, PTSD, and Anxiety Fuels Demand for Non-Invasive Behavioral Interventions
    • Integration of AI-Driven Personalization Enhances Cognitive Engagement in Digital Vaccine Delivery
    • Expansion of Prescription Digital Therapeutics (PDT) Framework Supports Regulatory Approvals
    • Digital Vaccine Development Benefits From Neuroplasticity Research and Stimulus Design Advancements
    • Use of Smartphones and Tablets as Delivery Platforms Increases Accessibility in Pediatric Populations
    • FDA and EMA Recognition of Software as a Medical Device (SaMD) Framework Accelerates Market Entry
    • Increased Use in Cognitive Training and Prevention of Neurodegenerative Disorders Broadens Applications
    • Rising Healthcare Cost Pressures Drive Interest in Scalable, Low-Cost Software-Based Interventions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Digital Vaccines Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Digital Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Digital Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Digital Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Smartphones Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Smartphones Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Smartphones Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Tablets Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Tablets Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Tablets Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diabetes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diabetes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Diabetes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Infectious Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Cardiovascular Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • JAPAN
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • CHINA
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • EUROPE
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Digital Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Digital Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Digital Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • FRANCE
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • GERMANY
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Digital Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Digital Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Digital Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • INDIA
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Digital Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Digital Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Digital Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Digital Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Digital Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Digital Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • AFRICA
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!